陶勇，云南大学生命科学学院研究员、博士生导师。2002 年本科毕业于华中农业大学植物科学专业，2009 年于中国科学院遗传与发育生物学研究所获理学博士学位（分子遗传学）。2009–2014 年任中国科学院北京基因组研究所助理研究员、副研究员；2014–2019 年在美国约翰霍普金斯大学（Johns Hopkins University）医学院从事博士后研究；2019–2022 年在美国弗雷德·哈钦森癌症中心（Fred Hutch Cancer Center）从事博士后研究。2022 年 6 月入职云南大学生命科学学院。 Yong Tao is a Professor and doctoral supervisor at the School of Life Sciences, Yunnan University. He received his B.S. in Plant Science from Huazhong Agricultural University in 2002 and his Ph.D. in Molecular Genetics from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, in 2009. He served as Assistant and then Associate Investigator at the Beijing Institute of Genomics, CAS (2009–2014), and conducted postdoctoral research at the Johns Hopkins University School of Medicine (2014–2019) and Fred Hutch Cancer Center (2019–2022). He joined Yunnan University in June 2022.
课题组以组织类器官、肿瘤细胞系、肿瘤类器官和小鼠模型为体系，综合运用遗传学、表观遗传学、基因组学与细胞生化方法，研究结肠干细胞的命运决定与结肠癌发生之间的关系，以及雄激素受体阳性前列腺癌在治疗过程中发生细胞命运转分化的分子机制，并致力于推动结肠癌与前列腺癌的临床管理。 The lab uses tissue organoids, cancer cell lines, tumor organoids, and mouse models, combining genetics, epigenetics, genomics, and cell biochemistry to study how colonic stem-cell fate decisions relate to colorectal tumorigenesis, and the molecular mechanisms of cell-fate transdifferentiation in androgen receptor-positive prostate cancer under therapy — with the goal of improving clinical management of both cancers.
相关工作以第一作者或共同作者发表于 Nature、Cancer Cell、PNAS、Clinical Epigenetics 等期刊。 This work has appeared in Nature, Cancer Cell, PNAS, and Clinical Epigenetics, among others.